Reduced expression level of mgmt mRNA and beta-catenin gene mutation in rat colon tumors

Tatsuya Kinjo1, Masumi Suzui, Takamitsu Morioka

  • 1Tumor Pathology, University of the Ryukyus Faculty of Medicine, Okinawa 903-0215, Japan. k038704@eve.u-ryukyu.ac.jp

Anticancer Research
|August 5, 2006
PubMed
Abstract

Insights

Reduced O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression and beta-catenin gene mutations are linked to rat colon tumor development. This suggests a potential role in tumorigenesis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • O6-methylguanine-DNA methyltransferase (MGMT) is a crucial DNA repair protein.
  • MGMT protects against DNA damage from alkylating carcinogens.

Purpose of the Study:

  • Investigate the relationship between Mgmt gene mRNA expression and beta-catenin gene mutations.
  • Examine these factors in azoxymethane (AOM) plus dextran sulfate sodium (DSS)-induced rat colon tumors.

Main Methods:

  • Analyzed 11 rat colon tumor samples induced by AOM plus DSS.
  • Identified beta-catenin gene mutations using PCR-SSCP.
  • Quantified Mgmt mRNA expression via RT-PCR.

Main Results:

  • 45% (5 out of 11) of tumors showed beta-catenin gene mutations.
  • Four out of five tumors with beta-catenin mutations exhibited decreased Mgmt mRNA expression (p<0.02).

Conclusions:

  • Reduced Mgmt mRNA expression and beta-catenin gene mutation may contribute to rat colon tumor development.
  • These molecular alterations could be key factors in chemical carcinogenesis.

Related Concept Videos